Latest Ulcerative colitis Stories
VSL#3, classified as medical food, is designated for the dietary management of UC, ileal pouch and IBS As clinical studies continue to validate the use of probiotics to help promote general gastrointestinal health, a growing U.S. market1 for probiotics indicates that the U.S. healthcare community and consumers alike are recognizing the value of these beneficial microorganisms. However, because most probiotics are classified as dietary supplements, directing patients to the best probiotic...
Mayo Clinic researchers have developed a new way to assess a common cause of chronic diarrhea, microscopic colitis, using the Microscopic Colitis Disease Activity Index. A study describing the index was released today during the American College of Gastroenterology 2011 Annual Scientific Meeting and Postgraduate Course in Washington. The index provides a consistent way to assess the condition's severity. "Until now, physicians have not had a way to objectively and consistently score the...
Fecal Transplants, Hepatitis C, Efficacy of Probiotics, Smoking's Impact on GI Health, Vitamin D in IBD Therapy, Adult IBS and Childhood Trauma Link Among Featured Science WASHINGTON, Oct. 31, 2011 /PRNewswire-USNewswire/ -- Many of the world's preeminent gastroenterologists have convened this week for the American College of Gastroenterology's (ACG) 76th Annual Scientific Meeting at the Gaylord National Hotel and Conference Center at the National Harbor to review the latest scientific...
ATLANTA, Oct. 28, 2011 /PRNewswire/ -- UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is marking the 2011 American College of Gastroenterology (ACG) meeting in Washington, D.C. by reinforcing its commitment to improving the lives of patients with Crohn's disease. At this year's ACG meeting, a large body of UCB data will highlight the potential role of inflammatory biomarkers in treatment of moderate to severe Crohn's disease. "ACG is an...
SAN DIEGO, Oct. 24, 2011 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® IBD sgi Diagnostic(TM) test. The PROMETHEUS IBD sgi Diagnostic is Prometheus' 4th-generation IBD diagnostic test and the first and only test to combine serologic, genetic, and inflammation markers, hence "sgi", in the proprietary Smart Diagnostic Algorithm for added diagnostic clarity. This novel...
LONDON, October 12, 2011 /PRNewswire/ -- - Two pivotal trials initiated for treatment of iron deficiency anaemia associated with ulcerative colitis and Crohn's disease - Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two...
PRINCETON, N.J., Oct. 11, 2011 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today the formation of a Medical Advisory Board (MAB) to provide medical/clinical strategic guidance to the Company as it relates to the development of SGX203 (oral beclomethasone dipropionate, or oral BDP) for the treatment of pediatric Crohn's disease. Comprised of pediatric gastroenterology thought leaders in the field of Crohn's...
Dr. Don J. Schiller, a renowned expert in Continent Ileostomy surgery, presented at the 2011 UOAA Conference in Reno, Nevada. The United Ostomy Associations of America (UOAA) is an association devoted to improving awareness of Ostomy surgery. Reno, NV (PRWEB) October 08, 2011 The UOAA or United Ostomy Associations of America held this year’s Conference with the theme “Seize the Opportunity†from August 7-11, 2011 in Reno, Nevada. The UOAA is an association devoted to...
HORSHAM, Pa., Sept. 29, 2011 /PRNewswire/ -- Season 10 American Idol contestant Casey Abrams has announced the top finalists in the national awareness campaign, IBD Icons, which celebrates the courage and persistence of those living with inflammatory bowel disease (IBD) and encourages them to never give in to their condition. Casey is asking Americans to vote for the two stories they find most inspiring at www.IBDIcons.com to help raise awareness and research funding for IBD. To view the...
Crohn disease (CD) and ulcerative colitis (UC) are the two most common forms of inflammatory bowel disease, affecting approximately 1 million people in the US. The severity of the symptoms and the frequency with which they recur varies widely among patients. Kenneth Smith and colleagues, at the University of Cambridge, United Kingdom, have now identified a gene expression profile that can divide patients with CD and UC into two otherwise undistinguishable subgroups -- those with a high...
